该试验预计将于2022年启动,其结果将为TAEUS装置在中国用于NAFLD的潜在商业化提供临床证据。
ENDRA(NDRA)首席执行官弗朗索瓦·米其隆(Francois Michelon)表...查看全文
智通财经APP预告,2021年5月18日,港美股上市公司活动及香港重要财经会议信息情况如下: 04:30 ENDRA Life Sciences, Inc.(NDRA.US) ENDRA Life Sciences, Inc.(NDRA.US)2021年第一季度业绩电话会 网络转播 04:30 GAN Limited(GAN.US) G... 网页链接
$Endra Life Sciences(NDRA)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001645460-19-000002 Act: 33 Size: 14 KB 网页链接
$Endra Life Sciences(NDRA)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001654954-19-014072 Act: 34 Size: 2 MB 网页链接
$Endra Life Sciences(NDRA)$ 8-K/A [Amend] Current report, item 1.01 Accession Number: 0001654954-19-013920 Act: 34 Size: 30 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060087 Size: 10 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060088 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060089 Size: 10 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060091 Size: 10 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060092 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060093 Size: 10 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-060084 Size: 9 KB 网页链接